4CPS-130 Use of non-specific immunoglobulins in burned paediatric patients: validation of the protocol of a tertiary hospital

BACKGROUND: Serious burns produce plasma extravasation which develops an important loss of immunoglobulins (Ig). In patients with a burned surface area (BSA) >15% IgG plasmatic levels decrease until 40 hours’ post-burn. PURPOSE: To evaluate the use of non-specific Ig in burned paediatric patients...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Eur J Hosp Pharm
Päätekijät: Sebastià, L Betriu, Arévalo, AG, Lalueza, P, Juárez, JC, Cabañas, MJ, Serramontmany, E, Martínez, Z, Balcells, J, Rossich, R
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Group 2018
Aiheet:
Section 4: Clinical pharmacy services
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535152/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.221
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia